266 related articles for article (PubMed ID: 15834638)
1. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
[TBL] [Abstract][Full Text] [Related]
2. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
3. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
Cohen Y; Rosenbaum E; Begum S; Goldenberg D; Esche C; Lavie O; Sidransky D; Westra WH
Clin Cancer Res; 2004 May; 10(10):3444-7. PubMed ID: 15161700
[TBL] [Abstract][Full Text] [Related]
4. IQGAP1 is an oncogenic target in canine melanoma.
Lee BH; Neela PH; Kent MS; Zehnder AM
PLoS One; 2017; 12(4):e0176370. PubMed ID: 28445541
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of BRAF mutation and extracellular regulated protein kinases activation in nasal mucosa melanomas].
Li HY; Zhou L; Tian J; Cong N
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3399-402. PubMed ID: 21223812
[TBL] [Abstract][Full Text] [Related]
6. Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation.
Yazdi AS; Ghoreschi K; Sander CA; Röcken M
Eur J Dermatol; 2010; 20(5):575-9. PubMed ID: 20605766
[TBL] [Abstract][Full Text] [Related]
7. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma.
Fowles JS; Denton CL; Gustafson DL
Vet Comp Oncol; 2015 Sep; 13(3):288-304. PubMed ID: 23745794
[TBL] [Abstract][Full Text] [Related]
9. BRAF and GNAQ mutations in melanocytic tumors of the oral cavity.
Cohen Y; Goldenberg-Cohen N; Akrish S; Shani T; Amariglio N; Dratviman-Storobinsky O; Kaplan I; Barshack I; Hirshberg A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Dec; 114(6):778-84. PubMed ID: 23159116
[TBL] [Abstract][Full Text] [Related]
10. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
11. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
12. Absence of BRAF mutations in UV-protected mucosal melanomas.
Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
[TBL] [Abstract][Full Text] [Related]
13. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
Simpson RM; Bastian BC; Michael HT; Webster JD; Prasad ML; Conway CM; Prieto VM; Gary JM; Goldschmidt MH; Esplin DG; Smedley RC; Piris A; Meuten DJ; Kiupel M; Lee CC; Ward JM; Dwyer JE; Davis BJ; Anver MR; Molinolo AA; Hoover SB; Rodriguez-Canales J; Hewitt SM
Pigment Cell Melanoma Res; 2014 Jan; 27(1):37-47. PubMed ID: 24128326
[TBL] [Abstract][Full Text] [Related]
14. BRAF somatic mutations in malignant melanoma and melanocytic naevi.
Thomas NE
Melanoma Res; 2006 Apr; 16(2):97-103. PubMed ID: 16567964
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
Saldanha G; Potter L; Daforno P; Pringle JH
Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
Gillard M; Cadieu E; De Brito C; Abadie J; Vergier B; Devauchelle P; Degorce F; Dréano S; Primot A; Dorso L; Lagadic M; Galibert F; Hédan B; Galibert MD; André C
Pigment Cell Melanoma Res; 2014 Jan; 27(1):90-102. PubMed ID: 24112648
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutations in conjunctival melanoma.
Gear H; Williams H; Kemp EG; Roberts F
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467
[TBL] [Abstract][Full Text] [Related]
19. Mutational Status of NRAS and BRAF Genes and Protein Expression Analysis in a Series of Primary Oral Mucosal Melanoma.
Hsieh R; Nico MM; Camillo CM; Oliveira KK; Sangueza M; Lourenço SV
Am J Dermatopathol; 2017 Feb; 39(2):104-110. PubMed ID: 28134726
[TBL] [Abstract][Full Text] [Related]
20. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
